• Aclacinomycin A: Advancing DNA Damage Research in Oncology

  2026-05-12

  This article provides a translational researcher’s lens on Aclacinomycin A (Aclarubicin), examining its mechanistic roles as a dual topoisomerase and proteasome inhibitor, benchmarking its cytotoxicity, and positioning it within the evolving landscape of DNA damage and apoptosis research. Drawing on recent mechanistic insights, particularly persistent rDNA lesions and PML-nucleolar dynamics, we outline experimental strategies, competitive context, and future perspectives on leveraging Aclacinomycin A in preclinical workflows. This analysis transcends typical product summaries by connecting APExBIO’s offering with actionable, evidence-based guidance and emerging mechanistic paradigms.

• Calpain Inhibitor I, ALLN: Technical Guidance for Research U

  2026-05-11

  Calpain Inhibitor I, ALLN is a potent, selective tool for inhibiting calpain and cathepsin proteases in apoptosis assays and ischemia-reperfusion injury models. It is best applied in mechanistic inflammation research where precise, reversible suppression of protease activity is required. This reagent is not intended for diagnostic or clinical applications.

• MTT for In Vitro Cell Proliferation: Precision Assay Strateg

  2026-05-11

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) sets the benchmark for quantifying cell metabolic activity and viability in translational research. Discover optimized workflows, advanced troubleshooting, and actionable insights—empowering robust, reproducible cell-based assays in drug discovery and disease modeling.

• DT-TRAP Refines Chemoproteomic Target Discovery via Low-Temp

  2026-05-10

  DT-TRAP introduces a streamlined chemoproteomic workflow combining rational dosing and low-temperature incubation to enhance the specificity of ligand-protein interaction profiling. This approach reduces nonspecific binding, lowers sample requirements, and enables more accurate drug target identification, setting a new benchmark for experimental optimization in chemical proteomics.

• Dovitinib (TKI-258): Advanced Workflows in Cancer Cell Resea

  2026-05-09

  Dovitinib (TKI-258) stands out as a multitargeted RTK inhibitor, empowering researchers to dissect complex signaling and apoptosis mechanisms in cancer models. This guide delivers actionable workflows, troubleshooting strategies, and context from recent cheminformatics advances to maximize data quality and translational impact.

• AZD0156: Applied Workflows for ATM Kinase Inhibition in Canc

  2026-05-09

  AZD0156 stands apart as a highly selective ATM kinase inhibitor, enabling precision modulation of DNA damage response pathways and metabolic vulnerabilities in cancer models. This guide translates recent mechanistic breakthroughs into actionable workflows, troubleshooting advice, and comparative insights for researchers seeking robust, reproducible results.

• D2HG Biosensors Reveal Metabolic Shifts in cGAMP-Stimulated

  2026-05-08

  Wang et al. (2025) engineered genetically encoded biosensors (DHsers) for real-time quantification of D-2-hydroxyglutarate (D2HG) in living cells by leveraging the allosteric mechanism of the prokaryotic regulator DhdR. Their work uncovers a direct link between STING pathway activation—specifically via 2'3'-cGAMP—and elevated D2HG levels, providing a platform to dissect metabolic-immune crosstalk in cancer and immunology research.

• Quercetin Inhibits Ferroptosis to Alleviate Liver Injury in

  2026-05-07

  This study demonstrates that quercetin directly inhibits the ACSL4/LPCAT3/ALOX15 ferroptosis pathway, significantly reducing liver injury in Wilson's Disease models by restoring lipid and iron homeostasis. The findings provide mechanistic insights into ferroptosis modulation and highlight quercetin's translational potential for targeted hepatic therapies.

• Injectable Hemostatic Adhesive Combats Non-Compressible Blee

  2026-05-07

  This study introduces a blue light-triggered, injectable hemostatic adhesive (GelMA/QCS/Ca2+) that addresses both rapid bleeding control and bacterial infection in non-compressible wounds. Through rigorous in vitro and in vivo models, the adhesive demonstrates superior hemostatic and antibacterial properties compared to commercial fibrin glue, highlighting its translational potential for emergency and trauma care.

• URB597 (KDS-4103): Precision FAAH Inhibition for Pain Resear

  2026-05-06

  URB597 (KDS-4103) offers researchers a potent and selective FAAH inhibitor for dissecting endocannabinoid signaling in pain, neuroinflammation, and neuroplasticity models. This guide translates recent experimental breakthroughs into actionable workflows, protocol parameters, and troubleshooting insights, positioning URB597 from APExBIO as an essential tool for translational research.

• Mechanisms of ZAK Activation at Collided Ribosomes: Cryo-EM

  2026-05-06

  This study elucidates how the MAP3K ZAK is activated at sites of ribosome collision, using biochemical and cryo-EM approaches. Findings provide a mechanistic blueprint for stress signaling at the ribosomal interface, with implications for kinase-targeted research.

• Gepotidacin: Applied Strategies for Antibacterial Research S

  2026-05-05

  Gepotidacin (GSK2140944) offers a potent, novel mechanism for inhibiting bacterial DNA replication, making it a cornerstone in antibiotic resistance research. This article delivers actionable protocols, advanced troubleshooting, and comparative insights to empower experimental workflows targeting multidrug-resistant pathogens.

• Poly (I:C): Synthetic Double-Stranded RNA Analog for Immune

  2026-05-05

  Poly (I:C) sets the standard for mimicking viral RNA and activating TLR3-driven immune pathways in both immunology and stem cell research. This article details applied workflows, troubleshooting insights, and novel protocol enhancements that leverage Poly (I:C) as a precision dendritic cell maturation and interferon inducer.

• WNT5a/GSK3/β-catenin Axis Regulates FAP Adipogenesis in Musc

  2026-05-04

  This study reveals that the WNT5a/GSK3/β-catenin signaling axis is a critical regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, cytometric, and transcriptomic methods, the authors demonstrate that targeting this pathway can limit fat infiltration and promote muscle regeneration, suggesting translational potential for myopathy therapies.

• PAD4-IN-2 TFA: Precision PAD4 Inhibition for Tumor Microenvi

  2026-05-04

  PAD4-IN-2 TFA (Compound 5i TFA) delivers highly selective, tumor-targeted PAD4 inhibition, enabling researchers to dissect NET formation and immune microenvironment modulation without off-target toxicity. This guide translates the latest mechanistic findings into actionable workflows and troubleshooting strategies for robust, reproducible cancer research.

459 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page